ZOMETA® – The Clinical Question of a Prostate Cancer Patient

View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics

ZOMETA Patient Case Study: Prostate Cancer

ZOMETA is the current standard of care for the prevention of skeletal-related events (SREs)

ZOMETAŽ Prostate Cancer Patient Case Study Dieter

Dieter V.

Aged 61 years
Manages a department store
Coaches his grandson's football team

How would you address Dieter's bone health?

Dieter's oncologist decided on a regimen of docetaxel + prednisone
Dieter is asymptomatic, and his oncologist is deciding whether to treat with ZOMETA^® in addition to chemotherapy

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.